Positive Allosteric Modulation of GABAB Receptors Ameliorates Sensorimotor Gating in Rodent Models

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2014 Apr 8

PMID 24703381

Citations 5

Authors

Roberto Frau

Valentina Bini

Giuliano Pillolla

Pari Malherbe

Alessandra Pardu

Andrew W Thomas

Paola Devoto

Marco Bortolato

Affiliations

Soon will be listed here.

Abstract

Background: Converging evidence points to the involvement of γ-amino-butyric acid B receptors (GABABRs) in the regulation of information processing. We previously showed that GABABR agonists exhibit antipsychotic-like properties in rodent models of sensorimotor gating deficits, as measured by the prepulse inhibition (PPI) of the acoustic startle reflex. The therapeutic potential of these agents, however, is limited by their neuromuscular side effects; thus, in this study, we analyzed whether rac-BHFF, a potent GABABR-positive allosteric modulator (PAM), could counter spontaneous and pharmacologically induced PPI deficits across various rodent models.

Methods: We tested the antipsychotic effects of rac-BHFF on the PPI deficits caused by the N-methyl-D-aspartate glutamate receptor antagonist dizocilpine, in Sprague-Dawley rats and C57BL/6 mice. Furthermore, we verified whether rac-BHFF ameliorated the spontaneous PPI impairments in DBA/2J mice.

Results: rac-BHFF dose-dependently countered the PPI deficits across all three models, in a fashion akin to the GABABR agonist baclofen and the atypical antipsychotic clozapine; in contrast with these compounds, however, rac-BHFF did not affect startle magnitude.

Conclusions: The present data further support the implication of GABABRs in the modulation of sensorimotor gating and point to their PAMs as a novel promising tool for antipsychotic treatment, with fewer side effects than GABABR agonists.

Citing Articles

Cleavage Speed and Blastomere Number in DBA/2J Compared with C57BL/6J Mouse Embryos.

Nishizono H, Uno K, Abe H J Am Assoc Lab Anim Sci. 2017; 56(1):11-17.

PMID: 28905710 PMC: 5250490.

Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Ma J, Leung L Psychopharmacology (Berl). 2017; 234(20):3129-3142.

PMID: 28756462 DOI: 10.1007/s00213-017-4705-7.

Differential Neural Responses Underlying the Inhibition of the Startle Response by Pre-Pulses or Gaps in Mice.

Moreno-Paublete R, Canlon B, Cederroth C Front Cell Neurosci. 2017; 11:19.

PMID: 28239338 PMC: 5302757. DOI: 10.3389/fncel.2017.00019.

Increased GABA receptor signaling in a rat model for schizophrenia.

Selten M, Meyer F, Ba W, Valles A, Maas D, Negwer M Sci Rep. 2016; 6:34240.

PMID: 27687783 PMC: 5043235. DOI: 10.1038/srep34240.

GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Fatemi S, Folsom T Schizophr Res. 2014; 167(1-3):42-56.

PMID: 25432637 PMC: 5301472. DOI: 10.1016/j.schres.2014.10.010.

References

Geyer M, Braff D, Swerdlow N . Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001; 156(2-3):117-54. DOI: 10.1007/s002130100811. View

Bakshi V, Swerdlow N, Geyer M . Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 1994; 271(2):787-94. View

Gulmann N, Bahr B, Andersen B, Eliassen H . A double-blind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr Scand. 1976; 54(4):287-93. DOI: 10.1111/j.1600-0447.1976.tb00122.x. View

Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 1997; 17(8):2921-7. PMC: 6573099. View

Gandal M, Sisti J, Klook K, Ortinski P, Leitman V, Liang Y . GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl Psychiatry. 2012; 2:e142. PMC: 3410621. DOI: 10.1038/tp.2012.69. View

Ishikawa M, Mizukami K, Iwakiri M, Asada T . Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Lett. 2005; 383(3):272-7. DOI: 10.1016/j.neulet.2005.04.025. View

Koek W, France C, Cheng K, Rice K . Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons. J Pharmacol Exp Ther. 2012; 341(2):369-76. PMC: 3336808. DOI: 10.1124/jpet.111.190975. View

Mizukami K, Ishikawa M, Hidaka S, Iwakiri M, Sasaki M, Iritani S . Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(2):393-6. DOI: 10.1016/s0278-5846(01)00247-0. View

Koek W, Cheng K, Rice K . Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: comparison with GABAB receptor agonists and drugs of abuse. J Pharmacol Exp Ther. 2013; 344(3):553-60. PMC: 3583500. DOI: 10.1124/jpet.112.202226. View

10.

Karl T, Duffy L, Scimone A, Harvey R, Schofield P . Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav. 2007; 6(7):677-87. DOI: 10.1111/j.1601-183X.2006.00298.x. View

11.

Takahashi K, Nagai T, Kamei H, Maeda K, Matsuya T, Arai S . Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol Psychiatry. 2006; 62(2):148-57. DOI: 10.1016/j.biopsych.2006.06.035. View

12.

Braff D, Geyer M, Swerdlow N . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001; 156(2-3):234-58. DOI: 10.1007/s002130100810. View

13.

Swerdlow N, Geyer M . Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998; 24(2):285-301. DOI: 10.1093/oxfordjournals.schbul.a033326. View

14.

Stavnes K, SPROTT R . Genetic analysis of active avoidance performance in mice. Psychol Rep. 1975; 36(2):515-21. DOI: 10.2466/pr0.1975.36.2.515. View

15.

RANDT C, Blizard D, Friedman E . Early life undernutrition and aggression in two mouse strains. Dev Psychobiol. 1975; 8(3):275-9. DOI: 10.1002/dev.420080313. View

16.

Kehrer C, Maziashvili N, Dugladze T, Gloveli T . Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia. Front Mol Neurosci. 2008; 1:6. PMC: 2525998. DOI: 10.3389/neuro.02.006.2008. View

17.

Bowery N . GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol. 2005; 6(1):37-43. DOI: 10.1016/j.coph.2005.10.002. View

18.

Jones C, Watson D, Fone K . Animal models of schizophrenia. Br J Pharmacol. 2011; 164(4):1162-94. PMC: 3229756. DOI: 10.1111/j.1476-5381.2011.01386.x. View

19.

Daskalakis Z, George T . Clozapine, GABA(B), and the treatment of resistant schizophrenia. Clin Pharmacol Ther. 2009; 86(4):442-6. DOI: 10.1038/clpt.2009.115. View

20.

Bortolato M, Frau R, Orru M, Piras A, Fa M, Tuveri A . Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology (Berl). 2007; 194(3):361-9. DOI: 10.1007/s00213-007-0845-5. View